KLF4 and acute myeloid leukemia: In a previous study, ABZ was identified by drug screening as a promising drug that can differentiate AML cells by stimulating the KLF4/DPYSL2A axis10; therefore, PBZ, and ABZ may share the same pathway during the exertion of anti-leukemic activity.